PATIENT REPORTED OUTCOMES AMONG PATIENTS RECEIVING TREATMENT FROM THE PEGLOTICASE PHASE 3 CLINICAL TRIALS FOR UNCONTROLLED GOUT

被引：1
|
作者：
Sparks, J. [1 ]
Obermeyer, K. [2 ]
Lamoreaux, B. [3 ]
机构：
[1] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA
[2] Horizon Therapeut Plc, Biostat, Deerfield, IL USA
[3] Horizon Therapeut Plc, Med Affairs, Deerfield, IL USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
QUALITY-OF-LIFE;
D O I：
10.1136/annrheumdis-2022-eular.1156
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1039
引用
收藏
页码：1643 / 1643
页数：1
相关论文
共 50 条
  • [11] PEGLOTICASE RESPONSE IMPROVEMENT BY CO-TREATMENT WITH METHOTREXATE: RESULTS FROM THE MIRROR OPEN-LABEL CLINICAL TRIAL IN PATIENTS WITH UNCONTROLLED GOUT
    Botson, J.
    Peloso, P. M.
    Obermeyer, K.
    Lamoreaux, B.
    Weinblatt, M. E.
    Peterson, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 442 - 442
  • [12] Improvements in Patient-Reported Outcomes After Treatment with SEL-212 in Adults with Refractory Gout: Results from Two Randomized Phase 3 Trials
    Strand, Vibeke
    Khanna, Puja
    Kivitz, Alan
    Kragh, Nana
    Falk, Aletta
    Azeem, Rehan
    Santin-Janin, Hugues
    Baraf, Herbert
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 700 - 703
  • [13] PATIENT REPORTED OUTCOMES IN CLINICAL TRIALS AND RANDOMISED CLINICAL TRIALS IN CHILDREN RECEIVING PALLIATIVE OR END OF LIFE CARE
    Barton, C.
    Brook, L.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S388 - S389
  • [14] Challenges of interpreting patient reported outcomes from clinical trials
    Fairclough, Diane L.
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (20)
  • [15] Patient-Reported Outcomes in Phase 3 Clinical Trials for Blood Cancers: A Systematic Review
    Patel, Kishan
    Ivanov, Alexandra
    Jocelyn, Tajmah
    Hantel, Andrew
    Garcia, Jacqueline S.
    Abel, Gregory A.
    JAMA NETWORK OPEN, 2024, 7 (06)
  • [16] PATIENT-REPORTED OUTCOMES VALIDATED IN PHASE 3 CLINICAL TRIALS: A TARGETED LITERATURE REVIEW
    Morga, A.
    Dibenedetto, S.
    Adiutori, R.
    Su, J.
    VALUE IN HEALTH, 2022, 25 (07) : S572 - S572
  • [17] Patient-reported outcomes validated in phase 3 clinical trials: a targeted literature review
    Morga, Antonia
    Dibenedetto, Silvia
    Adiutori, Rocco
    Su, Jun
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (07) : 955 - 962
  • [18] USING PATIENT REPORTED OUTCOMES TO DESCRIBE THE PATIENT EXPERIENCE ON PHASE I CLINICAL TRIALS
    Ferrell, Betty
    Sedhom, Ramy
    Koczywas, Marianna
    Chung, Vincent
    Ruel, Nora
    Smith, Thomas
    ONCOLOGY NURSING FORUM, 2021, 48 (02) : 59 - 59
  • [19] REVIEW OF PATIENT-REPORTED OUTCOMES IN PHASE II ONCOLOGY CLINICAL TRIALS
    Finnern, H. W.
    Danheiser, S.
    Barkalow, F.
    ANNALS OF ONCOLOGY, 2010, 21 : 183 - 183
  • [20] The value of patient-reported outcomes in early-phase clinical trials
    Ameeta Retzer
    Olalekan Lee Aiyegbusi
    Anna Rowe
    Philip N. Newsome
    Jessica Douglas-Pugh
    Sheeba Khan
    Saloni Mittal
    Roger Wilson
    Daniel O’Connor
    Lisa Campbell
    Sandra A. Mitchell
    Melanie Calvert
    Nature Medicine, 2022, 28 : 18 - 20
12345